Literature DB >> 8747823

Effects of prenatal exposure to cocaine and associated risk factors on language development.

M Mentis1, K Lundgren.   

Abstract

During the past decade there has been a dramatic increase in the number of children born with prenatal exposure to cocaine. However, there is very little hard data concerning the later development of these children. The purpose of this preliminary study was to compare the language development profiles of 5 children prenatally exposed to cocaine and associated risk factors to the language development profiles of a matched non-exposed control group in terms of analyses of the discourse-pragmatic, semantic, and form components of language. The language evaluation was based on the analysis of a 30-minute language sample. The results suggested differences between the two groups as well as differences within the cocaine-exposed group. The major differences between the two groups were in discourse-pragmatics although less marked differences in syntactic development were also found. The results are discussed in relation to the potential contribution of pertinent medical and environmental risk factors. The study suggests that for children with prenatal exposure to cocaine in combination with multiple associated risk factors, language development may be compromised.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747823     DOI: 10.1044/jshr.3806.1303

Source DB:  PubMed          Journal:  J Speech Hear Res        ISSN: 0022-4685


  9 in total

Review 1.  Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review.

Authors:  D A Frank; M Augustyn; W G Knight; T Pell; B Zuckerman
Journal:  JAMA       Date:  2001-03-28       Impact factor: 56.272

2.  Prenatal cocaine exposure and children's language functioning at 6 and 9.5 years: moderating effects of child age, birthweight, and gender.

Authors:  Marjorie Beeghly; Brett Martin; Ruth Rose-Jacobs; Howard Cabral; Tim Heeren; Marilyn Augustyn; David Bellinger; Deborah A Frank
Journal:  J Pediatr Psychol       Date:  2005-04-20

3.  Influence of prenatal cocaine exposure on early language development: longitudinal findings from four months to three years of age.

Authors:  Connie E Morrow; Emmalee S Bandstra; James C Anthony; Audrey Y Ofir; Lihua Xue; Mary B Reyes
Journal:  J Dev Behav Pediatr       Date:  2003-02       Impact factor: 2.225

4.  The effects of prenatal cocaine on language development at 10 years of age.

Authors:  Barbara A Lewis; Sonia Minnes; Elizabeth J Short; Paul Weishampel; Sudtida Satayathum; Meeyoung O Min; Suchitra Nelson; Lynn T Singer
Journal:  Neurotoxicol Teratol       Date:  2010-06-30       Impact factor: 3.763

5.  Prenatal cocaine exposure: an examination of childhood externalizing and internalizing behavior problems at age 7 years.

Authors:  Veronica H Accornero; James C Anthony; Connie E Morrow; Lihua Xue; Emmalee S Bandstra
Journal:  Epidemiol Psichiatr Soc       Date:  2006 Jan-Mar

6.  Neuropathological consequences of prenatal cocaine exposure in the mouse.

Authors:  Jia-Qian Ren; C J Malanga; Eddy Tabit; Barry E Kosofsky
Journal:  Int J Dev Neurosci       Date:  2004 Aug-Oct       Impact factor: 2.457

7.  Severity of prenatal cocaine exposure and child language functioning through age seven years: a longitudinal latent growth curve analysis.

Authors:  Emmalee S Bandstra; April L Vogel; Connie E Morrow; Lihua Xue; James C Anthony
Journal:  Subst Use Misuse       Date:  2004-01       Impact factor: 2.164

8.  Expressive and receptive language functioning in preschool children with prenatal cocaine exposure.

Authors:  Connie E Morrow; April L Vogel; James C Anthony; Audrey Y Ofir; Ana T Dausa; Emmalee S Bandstra
Journal:  J Pediatr Psychol       Date:  2004-10

9.  Language outcomes at 12 years for children exposed prenatally to cocaine.

Authors:  Barbara A Lewis; Sonia Minnes; Elizabeth J Short; Meeyoung O Min; Miaoping Wu; Adelaide Lang; Paul Weishampel; Lynn T Singer
Journal:  J Speech Lang Hear Res       Date:  2013-10       Impact factor: 2.297

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.